These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9614116

  • 1. Molecular features of the collagen V heparin binding site.
    Delacoux F, Fichard A, Geourjon C, Garrone R, Ruggiero F.
    J Biol Chem; 1998 Jun 12; 273(24):15069-76. PubMed ID: 9614116
    [Abstract] [Full Text] [Related]

  • 2. Structural requirements for heparin/heparan sulfate binding to type V collagen.
    Ricard-Blum S, Beraud M, Raynal N, Farndale RW, Ruggiero F.
    J Biol Chem; 2006 Sep 01; 281(35):25195-204. PubMed ID: 16815843
    [Abstract] [Full Text] [Related]

  • 3. Unraveling the amino acid sequence crucial for heparin binding to collagen V.
    Delacoux F, Fichard A, Cogne S, Garrone R, Ruggiero F.
    J Biol Chem; 2000 Sep 22; 275(38):29377-82. PubMed ID: 10862775
    [Abstract] [Full Text] [Related]

  • 4. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
    Brown JC, Sasaki T, Göhring W, Yamada Y, Timpl R.
    Eur J Biochem; 1997 Nov 15; 250(1):39-46. PubMed ID: 9431988
    [Abstract] [Full Text] [Related]

  • 5. Schwann cell adhesion to a novel heparan sulfate binding site in the N-terminal domain of alpha 4 type V collagen is mediated by syndecan-3.
    Erdman R, Stahl RC, Rothblum K, Chernousov MA, Carey DJ.
    J Biol Chem; 2002 Mar 01; 277(9):7619-25. PubMed ID: 11751872
    [Abstract] [Full Text] [Related]

  • 6. Characterization of type XI collagen-glycosaminoglycan interactions.
    Vaughan-Thomas A, Young RD, Phillips AC, Duance VC.
    J Biol Chem; 2001 Feb 16; 276(7):5303-9. PubMed ID: 11084037
    [Abstract] [Full Text] [Related]

  • 7. A collagen Vα1-derived fragment inhibits FGF-2 induced-angiogenesis by modulating endothelial cells plasticity through its heparin-binding site.
    Jia T, Vaganay E, Carpentier G, Coudert P, Guzman-Gonzales V, Manuel R, Eymin B, Coll JL, Ruggiero F.
    Matrix Biol; 2020 Dec 16; 94():18-30. PubMed ID: 32682018
    [Abstract] [Full Text] [Related]

  • 8. Site-directed mutagenesis of a putative heparin binding domain of avian lipoprotein lipase.
    Berryman DE, Bensadoun A.
    J Biol Chem; 1993 Feb 15; 268(5):3272-6. PubMed ID: 8429005
    [Abstract] [Full Text] [Related]

  • 9. Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion.
    LeBaron RG, Höök A, Esko JD, Gay S, Höök M.
    J Biol Chem; 1989 May 15; 264(14):7950-6. PubMed ID: 2524477
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA, Hoffman MP, Karmand AJ, Kleinman HK.
    Cancer Res; 2002 Jun 15; 62(12):3549-54. PubMed ID: 12068003
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The binding of heparin to type IV collagen: domain specificity with identification of peptide sequences from the alpha 1(IV) and alpha 2(IV) which preferentially bind heparin.
    Koliakos GG, Kouzi-Koliakos K, Furcht LT, Reger LA, Tsilibary EC.
    J Biol Chem; 1989 Feb 05; 264(4):2313-23. PubMed ID: 2914908
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
    Friedrich MV, Göhring W, Mörgelin M, Brancaccio A, David G, Timpl R.
    J Mol Biol; 1999 Nov 19; 294(1):259-70. PubMed ID: 10556044
    [Abstract] [Full Text] [Related]

  • 16. Interaction of collagen-like peptide models of asymmetric acetylcholinesterase with glycosaminoglycans: spectroscopic studies of conformational changes and stability.
    Doss-Pepe E, Deprez P, Inestrosa NC, Brodsky B.
    Biochemistry; 2000 Dec 05; 39(48):14884-92. PubMed ID: 11101304
    [Abstract] [Full Text] [Related]

  • 17. An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan.
    Tashiro K, Monji A, Yoshida I, Hayashi Y, Matsuda K, Tashiro N, Mitsuyama Y.
    Biochem J; 1999 May 15; 340 ( Pt 1)(Pt 1):119-26. PubMed ID: 10229666
    [Abstract] [Full Text] [Related]

  • 18. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.
    Talts JF, Andac Z, Göhring W, Brancaccio A, Timpl R.
    EMBO J; 1999 Feb 15; 18(4):863-70. PubMed ID: 10022829
    [Abstract] [Full Text] [Related]

  • 19. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I.
    Beher D, Hesse L, Masters CL, Multhaup G.
    J Biol Chem; 1996 Jan 19; 271(3):1613-20. PubMed ID: 8576160
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.